BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27635026)

  • 1. Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
    Wang J; Arulanandam R; Wassenaar R; Falls T; Petryk J; Paget J; Garson K; Cemeus C; Vanderhyden BC; Wells RG; Bell JC; Le Boeuf F
    J Nucl Med; 2017 Feb; 58(2):221-227. PubMed ID: 27635026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus.
    Haddad D; Chen NG; Zhang Q; Chen CH; Yu YA; Gonzalez L; Carpenter SG; Carson J; Au J; Mittra A; Gonen M; Zanzonico PB; Fong Y; Szalay AA
    J Transl Med; 2011 Mar; 9():36. PubMed ID: 21453532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter.
    Gholami S; Haddad D; Chen CH; Chen NG; Zhang Q; Zanzonico PB; Szalay AA; Fong Y
    Surgery; 2011 Dec; 150(6):1040-7. PubMed ID: 22136819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
    Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y
    PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.
    Jun KH; Gholami S; Song TJ; Au J; Haddad D; Carson J; Chen CH; Mojica K; Zanzonico P; Chen NG; Zhang Q; Szalay A; Fong Y
    J Exp Clin Cancer Res; 2014 Jan; 33(1):2. PubMed ID: 24383569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.
    Eveno C; Mojica K; Ady JW; Thorek DL; Longo V; Belin LJ; Gholami S; Johnsen C; Zanzonico P; Chen N; Yu T; Szalay AA; Fong Y
    Surgery; 2015 Feb; 157(2):331-7. PubMed ID: 25616946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.
    Gholami S; Chen CH; Belin LJ; Lou E; Fujisawa S; Antonacci C; Carew A; Chen NG; De Brot M; Zanzonico PB; Szalay AA; Fong Y
    Breast Cancer Res; 2013 Mar; 15(2):R26. PubMed ID: 23506710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic vaccinia virotherapy for endometrial cancer.
    Liu YP; Wang J; Avanzato VA; Bakkum-Gamez JN; Russell SJ; Bell JC; Peng KW
    Gynecol Oncol; 2014 Mar; 132(3):722-9. PubMed ID: 24434058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
    Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ
    Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.
    Rajecki M; Sarparanta M; Hakkarainen T; Tenhunen M; Diaconu I; Kuhmonen V; Kairemo K; Kanerva A; Airaksinen AJ; Hemminki A
    PLoS One; 2012; 7(3):e32871. PubMed ID: 22412937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
    Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
    Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer.
    Haddad D; Zanzonico PB; Carlin S; Chen CH; Chen NG; Zhang Q; Yu YA; Longo V; Mojica K; Aguilar RJ; Szalay AA; Fong Y
    J Nucl Med; 2012 Dec; 53(12):1933-42. PubMed ID: 23139088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer.
    Woo Y; Zhang Z; Yang A; Chaurasiya S; Park AK; Lu J; Kim SI; Warner SG; Von Hoff D; Fong Y
    J Am Coll Surg; 2020 Apr; 230(4):709-717. PubMed ID: 32032721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter.
    Hakkarainen T; Rajecki M; Sarparanta M; Tenhunen M; Airaksinen AJ; Desmond RA; Kairemo K; Hemminki A
    Clin Cancer Res; 2009 Sep; 15(17):5396-403. PubMed ID: 19706820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene.
    Merron A; Peerlinck I; Martin-Duque P; Burnet J; Quintanilla M; Mather S; Hingorani M; Harrington K; Iggo R; Vassaux G
    Gene Ther; 2007 Dec; 14(24):1731-8. PubMed ID: 17960161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
    Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
    Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma.
    Belin LJ; Ady JW; Lewis C; Marano D; Gholami S; Mojica K; Eveno C; Longo V; Zanzonico PB; Chen NG; Szalay AA; Fong Y
    Surgery; 2013 Sep; 154(3):486-95. PubMed ID: 23890748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.